Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
The global healthcare distribution market reached a value of approximately USD 935.46 billion in 2023. The market is further estimated to grow at a CAGR of 7.1% in the forecast period of 2024-2032.
Base Year
Historical Year
Forecast Year
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The market for healthcare distribution is propelled by the increasing importance of generics and the expanding biosimilars and medical equipment sectors, driven by technological advancements. Factors like track and trace solutions, speciality drug dispensing, and biopharmaceutical acceptance aid the market, alongside the rising popularity of generics in developing regions.
Generic drugs are identical to brand-name drugs in every aspect, offering the same benefits and risks. They are cost-effective as they don't incur developmental expenses. A robust distribution system is crucial due to increased demand globally. India alone had 23,581 government hospitals and 22 central government hospitals in 2019.
E-commerce integration, distribution of personalised medicine, progress in medical equipment, embracing track and trace solutions are the major trends impacting the global healthcare distribution market growth.
Healthcare distribution networks are increasingly integrating e-commerce platforms to streamline procurement and distribution processes, thereby improving accessibility and efficiency in delivering medical supplies and pharmaceuticals.
Distribution systems are adjusting to incorporate personalised medicine, necessitating custom logistics solutions for efficient delivery of tailored treatments to patients globally.
Technological breakthroughs are driving the advancement of cutting-edge medical equipment, which in turn, is fuelling the growth of the market.
The heightened utilisation of track and trace technologies aims to enhance supply chain transparency and combat the proliferation of counterfeit products through increased monitoring.
The demand for generic drugs and biosimilars is increasing due to their cost-effectiveness and efficacy. Technological advancements are fuelling the development of advanced medical equipment. Track and trace solutions are gaining traction for supply chain transparency. Specialized distribution channels are emerging for dispensing speciality drugs.
Biopharmaceutical acceptance is rising for treating various diseases. The global market is expanding, driven by the popularity of generics in developing regions, requiring robust distribution networks for timely delivery.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
“Healthcare Distribution Market Report and Forecast 2024-2032” offers a detailed analysis of the market based on the following segments:
Market Breakup by Type
Market Breakup by End Use
Market Breakup by Region
Retail pharmacies have emerged as a significant end user of healthcare distribution services, especially for pharmaceutical products.
Retail pharmacies, conveniently located in communities, ensure swift access to medications and over-the-counter items, offering patient education, preventive care, and specialised chronic disease management programs for comprehensive healthcare support.
On the other hand, hospital pharmacies are crucial within healthcare institutions, delivering comprehensive care, clinical assistance, formulary oversight, and customised medication solutions, ensuring patient safety and evidence-based practices.
By type, medical device distribution services significantly contribute to the healthcare distribution market revenue. Companies specialise in the distribution of various medical devices, ensuring proficiency in handling, and delivering specialized equipment tailored to specific needs.
Medical device distribution services specialize in managing a broad array of medical equipment, ensuring proficiency, effectiveness, and adherence to regulations, facilitated by advanced inventory management systems for optimal stock levels and efficient operations.
Biopharmaceutical product distribution services excel in maintaining precise temperature control, ensuring regulatory adherence, streamlining supply chain efficiency, and offering specialized handling to ensure the safe transportation and delivery of fragile products.
The market players offer pharmaceutical sourcing and distribution services, delivering pharmaceutical products, business solutions, and value-added services that enhance access to healthcare. Founded in 1833, with its headquarters in the United States, McKesson is a globally recognized healthcare firm listed on the NYSE (MCK), delivering pharmaceutical distribution, medical supplies, and healthcare technology solutions. Established in 1971, and situated in the United States, Cardinal Health (CAH) is a prominent healthcare servic... Tracing its roots to 2001, AmerisourceBergen Corporation (ABC), headquartered in Pennsylvania, stands as a For... Founded in 1882, with its main offices located in Richmond, Virginia, Owens & Minor, Inc. (OMI) is a healthcar... *Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*McKesson Corporation (MCK)
Cardinal Health (CAH)
AmerisourceBergen Corporation (ABC)
Owens & Minor, Inc. (OMI)
Other players in the market are Morris & Dickson Co. L.L.C., Priority Healthcare Distribution, Inc., FFF Enterprises, Inc., Attain Med, and Dakota Drug, Inc., among others.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The Asia Pacific region holds a leading position in the healthcare distribution sector, primarily driven by escalating healthcare expenditures.
Asia Pacific's continual advancement in the healthcare technology and the substantial patient populace are poised to fuel the growth of the market.
As per NCBI's 2023 report, sustained governmental initiatives have led to the establishment of a total of 1,030,935 healthcare institutions across mainland China by the conclusion of 2021, comprising 36,570 hospitals and 977,790 primary-level clinics.
North America anticipates notable growth in the healthcare distribution market driven by increased demand for speciality drugs and generics, alongside extensive adoption of advanced technologies like AI and blockchain, enhancing supply chain efficiency.
Healthcare Distribution Market Size
Healthcare Distribution Market Growth
Healthcare Distribution Market Trends
Healthcare Distribution Market Share
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
The healthcare distribution market was valued at USD 935.46 billion in 2023.
The market is projected to grow at a CAGR of 7.1% between 2024 and 2032.
The market is categorised according to the type, which includes pharmaceutical product distribution services, medical device distribution services and biopharmaceutical product distribution services.
The major market drivers include growing significance of generics, increasing prevalence of chronic diseases, and the expanding biosimilars and medical equipment industries due to the advancement in technology.
The e-commerce integration and the growing demand for personalised medications are expected to be key trends guiding the growth of the market.
Based on the end use, the market is divided into retail pharmacies, hospital pharmacies, and others.
The market is broken down into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
The key market players are McKesson Corporation [MCK (NYSE)], Cardinal Health [CAH (NYSE)], AmerisourceBergen Corporation [ABC (NYSE)], Owens & Minor, Inc. [OMI (NYSE)], Morris & Dickson Co. L.L.C., Priority Healthcare Distribution, Inc., FFF Enterprises, Inc., Attain Med, and Dakota Drug, Inc., among others.
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
REPORT FEATURES | DETAILS |
Base Year | 2023 |
Historical Period | 2017-2023 |
Forecast Period | 2024-2032 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Type |
|
Breakup by End Use |
|
Breakup by Region |
|
Market Dynamics |
|
Competitive Landscape |
|
Companies Covered |
|
Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
Purchase Full Report
Datasheet
Single User License
One User
Five User License
Five Users
Corporate License
Unlimited Users
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
Share